Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 2:08 PM
Ignite Modification Date: 2025-12-24 @ 2:08 PM
NCT ID: NCT06279195
Eligibility Criteria: Inclusion Criteria Idiopathic pelvic pain (40 participants): * Self-report an average non-menstrual pelvic pain rating of ≥ 2/10 (on a 0 to 10 Numeric Rating Scale) over the past 6 months. * Not have received a prior diagnosis attributed to a secondary cause (e.g., leiomyoma, endometriosis). Endometriosis (20 participants) * Self-report an average non-menstrual pelvic pain rating of ≥ 2/10 (on a 0 to 10 Numeric Rating Scale) over the past * Previously confirmed surgical diagnosis of stage III-IV endometriosis, indicating potential remission. Exclusion Criteria: * History of blood clots, * Allergies to REL-CT ingredients * Diabetes * Migraines * Osteoporosis * Vascular disease * Hormone-sensitive cancers * Smoking. * Missing limbs * Paralysis, * Conditions associated with irregular menses * Congenital conditions affecting reproductive function * Intrauterine device use * Pelvic inflammatory conditions * Active genitourinary infections, * Inability to read or comprehend the informed consent document written in English * History of metallic implants, history of metallic injury, any condition precluding investigation with MRI * BMI exceeding 40 * Uncontrolled thyroid dysfunction * Adrenal dysfunction * Renal disorders * Liver disorders * Coagulopathy, * Gastrointestinal conditions or surgeries that may affect absorption
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 35 Years
Study: NCT06279195
Study Brief:
Protocol Section: NCT06279195